by on February 23, 2024
The circulating cell-free tumor DNA market plays a vital role as they provide non-invasive options for cancer diagnosis and prognosis. With advantages such as ease of procurement through blood draws and ability to detect cancer across all stages, demand for circulating cell-free tumor DNA is increasing globally. The Global circulating cell-free tumor DNA Market is estimated to be valued at US$ 7.03 Mn in 2024 and is expected to exhibit a CAGR of 6.4% over the forecast period 2024 to 2030.   ...
15 views 0 likes
by on January 22, 2024
  Circulating cell-free tumor DNA, also known as blood-based biomarkers, are useful tools in cancer diagnosis and treatment monitoring. They provide genomic information that helps in understanding the molecular profiles of tumors and detecting cancer early. Cell-free DNA can efficiently monitor treatment response and detect relapse or resistance to therapy. The global circulating cell-free tumor DNA Market is estimated to be valued at US$ 6.1 Bn in 2023 and is expected to exhibit a CAGR of...
19 views 0 likes